Companion Diagnostics Market PDF: Global Size, Share, Trends, Analysis, Growth & Forecast to 2020-2025

1. Global Companion Diagnostics Market Research Report and Forecast 2025 www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145

2. About IMARC WHO WE ARE? • We are a leading market research firm with expertise in market intelligence and business research • We deliver high quality, well- knitted, meaningful studies • We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions WHAT DO WE DO? • Market research and business insights • Competitive intelligence and benchmarking • Strategy consulting • Consumer surveys and feedback analysis • Social and rural research • Market entry strategy • Syndicated Reports WHAT DO WE COVER? • Food And beverages • Dairy and dairy products • Agriculture and farming • Chemicals and materials • FMCG • Paper and packaging • Healthcare • Machinery, electronics and semiconductors WHO DO WE SERVE? • Collaborating with fortune 500 companies and SMEs • Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.

3. What We Do Competitive Intelligence and Benchmarking At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players. Cost Modeling and Cost Forecasting A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions. Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic Country Entry Strategy IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more. Consumer Survey & Feedback Reports Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services Consumer Survey & Feedback Reports Competitive Intelligence and Benchmarking Cost Modeling and Cost Forecasting Market Research & Business Insights Country Entry Strategy

4. REPORT OBJECTIVES & Highlight

5. Report Description The global companion diagnostics market grew at a CAGR of around 15% during 2014-2019. Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients. Request for a free sample copy of this report: https://www.imarcgroup.com/companion-diagnostics-market/requestsample Market Trends: The market is primarily driven by the increasing incidences of various forms of cancer on the global level. Companion diagnostics are widely used in advanced oncology healthcare for targeting biomarker identification and delivering targeted therapies to patients, thereby providing a thrust to the market growth. There has also been a significant increase in the demand for in-vitro diagnostics among the masses. This, along with the growing preference for personalized healthcare (PHC) and precision medicine in the healthcare sector, is facilitating the uptake of these diagnostics. Apart from this, there has been a rise in the utilization of targeted drugs and therapies for treating several infectious, cardiovascular, neurological, and inflammatory conditions. Coupled with the development of next-generation sequencing (NGS) and the increasing number of clinical trials, this is creating a positive outlook for the market. Additionally, several regulatory bodies, such as the US Food and Drug Administration (US FDA), have provided a defined structure for companion diagnostic development while encouraging the market players to conduct research activities in this field. The continual launch of new biomarkers, as well as the increasing number of collaborations between two or more companies for developing novel companion diagnostic products, is also providing an impetus to the market growth. The market is further driven by the rising application of companion diagnostics for analyzing the efficacy of COVID-19 drugs among patients undergoing oncology therapies. On account of the aforementioned factors, the market is anticipated to witness strong growth during 2020-2025.

6. Report Description Companion Diagnostics Market 2020-2025: Segmentation and Analysis of Top Keyplayers. Historical, Current and Future Market Trends Breakup by Product and Services: • Assays, Kits and Reagents • Software and Services Breakup by Technology: • Immunohistochemistry (IHC) • Polymerase Chain Reaction (PCR) • In-situ Hybridization (ISH) • Real-time PCR (RT-PCR) • Gene Sequencing • Others Explore full report with table of contents: https://www.imarcgroup.com/companion-diagnostics-market Breakup by End-Use Industry: • Pharmaceutical & Biopharmaceutical Companies • Reference Laboratories • Contract Research Organizations • Others

7. Report Description Market Breakup by Indication: • Cancer • Neurological Diseases • Infectious Diseases • Cardiovascular Diseases • Others Breakup by Region: •North America • • United States Canada •Asia Pacific • • • • • China Japan India South Korea Australia

8. Report Description • • Indonesia Others •Europe • • • • • • • Germany France United Kingdom Italy Spain Russia Others •Latin America • • • Brazil Mexico Others •Middle East and Africa

9. Report Description Key Questions Answered in This Report: • • • • • • • • • • • How has the global companion diagnostics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global companion diagnostics market? What are the key regional markets? What is the breakup of the market based on the product & services? What is the breakup of the market based on the technology? What is the breakup of the market based on the indication? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global companion diagnostics market and who are the key players? What is the degree of competition in the industry?

10. Table of Contents

11. Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Companion Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product & Service 6.1 Assays, Kits and Reagents 6.1.1 Market Trends 6.1.2 Market Forecast

12. Table of Contents 6.2 Software and Services 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technology 7.1 Immunohistochemistry (IHC) 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Polymerase Chain Reaction (PCR) 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 In-situ Hybridization (ISH) 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Real-time PCR (RT-PCR) 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Gene Sequencing 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8 Market Breakup by Indication 8.1 Cancer 8.1.1 Market Trends 8.1.2 Major Types

13. Table of Contents 8.1.2.1 Lung Cancer 8.1.2.2 Breast Cancer 8.1.2.3 Colorectal Cancer 8.1.2.4 Gastric Cancer 8.1.2.5 Melanoma 8.1.2.6 Others 8.1.3 Market Forecast 8.2 Neurological Diseases 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Infectious Diseases 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Cardiovascular Diseases 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End User 9.1 Pharmaceutical & Biopharmaceutical Companies 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Reference Laboratories 9.2.1 Market Trends 9.2.2 Market Forecast

14. Table of Contents 9.3 Contract Research Organizations 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends

15. Table of Contents 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast

16. Table of Contents 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats

17. Table of Contents 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Abbott Laboratories 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Agilent Technologies 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.2.4 SWOT Analysis

18. Table of Contents 15.3.3 BioMerieux 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 Danaher Corporation 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Roche Holding AG 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.4 SWOT Analysis 15.3.6 Myriad Genetics Inc. 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.6.4 SWOT Analysis 15.3.7 Siemens Healthcare 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials

19. Table of Contents 15.3.7.4 SWOT Analysis 15.3.8 Thermo Fisher Scientific Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis

20. Report FAQs Team Profile Team Profile

21. Team Profile Growing team of 150+ employees with deep market knowledge Engineers and Post Graduates Account for 75% of our Team Post Graduates 30% Over 1000 Independent Consultants from different sectors Engineers 45% Talents from some of the top universities modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Non Engineering Graduates 15% Commercial and non-commercial relationships with some of the top research institutes Others 10%

22. Report FAQs Words From Client

23. Words From Client “We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.” Procurement Technology Manager – Global FMCG Giant -Global “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.” -Vice President Marketing – European Diagnostic Company “We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.” -National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company

24. Report FAQs Report FAQs

25. Report FAQs 01 02 03 Do you provide market share information for a specific country/segment? Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements. My research requirement is very specific; can I customized the report? Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations. How do you arrive at the market numbers? Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis. The third step is data validation from industry experts, key players and other stakeholders. 04 05 I have a pre-defined budget. Can I buy chapters/sections of the report? We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement. Do you offer post sales support? Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.

26. Report FAQs 06 07 Who are your client? We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services How will I receive the report? The report in a PDF and Excel format will be sent to you electronically at your registered email address. Moreover, PPT and Word formats are also delivered to clients, on special requests. 08 09 How often does IMARC update studies? Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status. Will I have to pay for the post-sale customization needs? We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.

27. SOME OF OUR KEY CUSTOMERS